Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Regulus Therapeutics Inc (NASDAQ: RGLS)

 
RGLS Technical Analysis
5
As on 24th Jun 2025 RGLS STOCK Price closed @ 8.16 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.80 & Strong Buy for SHORT-TERM with Stoploss of 1.53 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RGLSSTOCK Price

Open 8.15 Change Price %
High 8.18 1 Day 0.02 0.25
Low 8.07 1 Week 0.08 0.99
Close 8.16 1 Month 0.29 3.68
Volume 9338597 1 Year 6.85 522.90
52 Week High 8.30 | 52 Week Low 0.97
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LCID 2.16 5.37%
HCTI 0.03 50.00%
NVDA 159.34 1.33%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
PLUG 1.47 5.00%
WINT 0.93 20.78%
BTBT 2.94 11.79%
LILM 0.05 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
TBIO 0.30 500.00%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
CTHR 0.22 -77.08%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.12 -62.50%
 
 
RGLS
Daily Charts		 RGLS
Intraday Charts		 Whats New @
Bazaartrend		 RGLS
Free Analysis
 
RGLS Important Levels Intraday
RESISTANCE8.37
RESISTANCE8.30
RESISTANCE8.26
RESISTANCE8.22
SUPPORT8.10
SUPPORT8.06
SUPPORT8.02
SUPPORT7.95
 
RGLS Forecast July 2025
Share
4th UP Forecast9.43
3rd UP Forecast9.02
2nd UP Forecast8.77
1st UP Forecast8.52
1st DOWN Forecast7.8
2nd DOWN Forecast7.55
3rd DOWN Forecast7.3
4th DOWN Forecast6.89
 
RGLS Weekly Forecast
4th UP Forecast8.70
3rd UP Forecast8.53
2nd UP Forecast8.42
1st UP Forecast8.31
1st DOWN Forecast8.01
2nd DOWN Forecast7.90
3rd DOWN Forecast7.79
4th DOWN Forecast7.62
 
RGLS Forecast2025
4th UP Forecast22.65
3rd UP Forecast18
2nd UP Forecast15.13
1st UP Forecast12.26
1st DOWN Forecast4.06
2nd DOWN Forecast1.19
3rd DOWN Forecast-1.68
4th DOWN Forecast-6.33
 
 
RGLS Other Details
Segment EQ
Market Capital 39612044.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
RGLS Address
RGLS
 
RGLS Latest News
 
Your Comments and Response on Regulus Therapeutics Inc
 
RGLS Business Profile
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS4326, an anti-miR targeting miR-17, which is in Phase 1 development for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products, which include RGLS5579 glioblastoma multiforme program; and Hepatitis B virus, non-alcoholic steatohepatitis, and cell therapies programs. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California. Address: 4224 Campus Point Court, San Diego, CA, United States, 92121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service